NeuroPace, Inc. (NPCE)
16.52
+0.25
(+1.54%)
USD |
NASDAQ |
Dec 10, 12:06
NeuroPace Market Cap: 550.24M for Dec. 10, 2025
Market Cap Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
Market Capitalization Definition
Market Capitalization measures the total value of a company based on their stock price multiplied by the shares outstanding. This metric is important because it gives you an idea of the size of a company, and how the size has changed over time. When studying companies from a relative basis, it would make sense to compare companies that have a similar market capitalization because factors like market share, economies of scale, and business models would also be similar.
Market Cap Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Market Cap Benchmarks
| Standard BioTools, Inc. | 563.39M |
| LENSAR, Inc. | 135.57M |
| Intelligent Bio Solutions, Inc. | 6.998M |
| Adagio Medical Holdings, Inc. | 18.85M |
| Movano, Inc. | 6.779M |
Market Cap Related Metrics
| PS Ratio | 5.546 |
| Price to Book Value | 29.71 |
| Price | 16.52 |
| Earnings Yield | -4.56% |